Showing results (131-140 of 265) with videos related to

Sort By:
Pageof 27
Archiv Der Pharmazie|June 15, 2007
New 4-[(1-benzyl-1H-indol-3-yl)carbonyl]-3-hydroxyfuran-2(5H)-ones, beta-diketo acid analogs as HIV-1 integrase inhibitorsStefania Ferro, Maria Letizia Barreca, Laura De Luca, et al.
Bioorganic & Medicinal Chemistry|August 24, 2014
Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integraseDaoguang Zhang, Bikash Debnath, Shenghui Yu, et al.
Journal of Medicinal Chemistry|April 4, 2003
N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of actionIrene M Lagoja, Christophe Pannecouque, Arthur Van Aerschot, et al.
Retrovirology|January 14, 2018
Inhibitors of the integrase-transportin-SR2 interaction block HIV nuclear importJonas Demeulemeester, Jolien Blokken, Stéphanie De Houwer, et al.
Reviews in Medical Virology|March 23, 2024
Pharmacological advances in anti-retroviral therapy for human immunodeficiency virus-1 infection: A comprehensive reviewNursyuhada Azzman, Muhammad Shoaib Ali Gill, Sharifah Syed Hassan, et al.
AIDS (London, England)|December 4, 2004
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel, et al.
The Journal of Biological Chemistry|February 27, 2009
Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZKoen Bartholomeeusen, Frauke Christ, Jelle Hendrix, et al.
Cell Host & Microbe|December 20, 2014
HIV-1 integrase variants retarget viral integration and are associated with disease progression in a chronic infection cohortJonas Demeulemeester, Sofie Vets, Rik Schrijvers, et al.
Journal of Virology|January 28, 2006
Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virusLinos Vandekerckhove, Frauke Christ, Bénédicte Van Maele, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2008
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole seriesLaura De Luca, Maria Letizia Barreca, Stefania Ferro, et al.
Pageof 27